New drugs targeting calcitonin gene-related peptide for the management of migraines-Reference-Cited by-同舟云学术

New drugs targeting calcitonin gene-related peptide for the management of migraines

Published:2023-10-02 Issue:4 Volume:28 Page:233-240
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Tana Claudio¹,Cipollone Francesco²,Giamberardino Maria Adele¹³,Martelletti Paolo⁴^ORCID

Affiliation:

1. Headache Center, Geriatrics Clinic, SS Annunziata Hospital of Chieti, Chieti, Italy

2. Department of Medicine and Science of Aging, Medical Clinic, SS. Annunziata Hospital of Chieti, “G. D’Annunzio” University of Chieti, Chieti, Italy

3. Department of Medicine and Science of Aging and CAST, G. D’Annunzio University of Chieti, Chieti, Italy

4. School of Health Sciences, Unitelma Sapienza University of Rome, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2023.2288334

Reference59 articles.

1. Emerging experimental drugs in clinical trials for migraine: observations and key talking points

2. microRNA profiling in atherosclerosis, diabetes, and migraine

3. Global, regional, and national time trends in incidence for migraine, from 1990 to 2019: an age-period-cohort analysis for the GBD 2019

4. The International Classification of Headache Disorders, 3rd edition (beta version)

5. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis;The Journal of Headache and Pain;2024-04-10

2. Health equity, care access and quality in headache – part 1;The Journal of Headache and Pain;2024-01-29